Medifast Inc (MED) Stock Price, Quote & News

Company Profile

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding,...

Industry: Personal Services

Sector: Consumer Cyclical

Phone: 410 581 8042

Website: medifastinc.com

Address:

100 International Drive, 18th Floor, Baltimore, United States

bginvest Dec. 4 at 8:40 PM

$MED $OTLY if i should put money in this sector health food ( waiting ) I would recommend OTLY at this point but I am personally only watching right now MED is shrinking as a company for longer period without profit there probably is continuing OTLY is growing but are expensive compared with other growth companies But if I should choose one it would be OTLY anytime I am staying on the sideline and hoping for a investment in OTLY when it’s closer to be profitable and if there still is growth they could’ve a bright future but still need money growth Best of luck 😘🤞🏦

1 · Reply

Iightning Dec. 4 at 8:11 AM

1ightning® Premium Options Alert (Actionable) Ticker: $MED Contract: Dec 19 $10C Entry: 1.07 Exit: 2.13 Return: +98.37% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

Investor6 Dec. 3 at 5:33 PM

Cheap rofitable stocks with also negative Enterprise Value. $TRVG GTEC $MED TRVG: unloved by the vast majority of the analysts, they see squeezed margins, no growth for the near future. Are they right? GTEC: A microcap with improved results, but without recent news, in a market where such small stocks are invisible, for now at least. MED: Revenues dropped, analysts are cautious, but the management believes things will improve in 2026 with new business segments.

0 · Reply

Iightning Dec. 2 at 2:46 AM

**1ightning® Premium Options Alert (Actionable)** **Ticker:** $MED **Contract:** Dec 19 $25C **Entry:** 0.29 **Exit:** 0.39 **Return:** **+35.43% ROI** This is the level of accuracy our VIP desk delivers daily. If you want **institutional-grade scalps without the noise**, join us. **Unlock VIP Access → https://1ightning.com**

0 · Reply

Estimize Nov. 26 at 9:00 PM

Wall St is expecting -0.82 EPS for $MED Q4 [Reporting 02/24 AMC] http://www.estimize.com/intro/med?chart=historical&metric_name=eps&utm_con

0 · Reply

Iightning Nov. 26 at 5:46 AM

1ightning® Options Trade Alert (Actionable) | Buy $MED Dec 19 $12 Call | Enter: $0.07 Exit: $0.13 | Profit: 90.22% ROI | https://1ightning.com

0 · Reply

FRAGMENTS Nov. 26 at 3:08 AM

$CNC $CNC $UNH $MED $MPW

1 · Reply

Iightning Nov. 25 at 3:55 PM

1ightning® Options Trade Alert (Actionable) | Buy $MED Dec 19 $12 Call | Enter: $0.07 Exit: $0.13 | Profit: 90.22% ROI | https://1ightning.com

0 · Reply

FRAGMENTS Nov. 25 at 1:15 PM

$CNC Deep Value Report Updated — Part 2 on $CNC is live. 🩺📊 From “de-risked” guidance to a $6.7B goodwill hit, we walk through the 2025 ACA / Medicaid shock, HBR math and what mid-cycle EPS really looks like now. If you care about managed care, policy risk and cash flow. HERE: https://cundilldeepvalue.substack.com/p/fragments-deep-value-report-centene $UNH $MED $MPW

0 · Reply

Iightning Nov. 25 at 4:49 AM

1ightning® Options Trade Alert (Actionable) | Buy $MED Dec 19 $12 Call | Enter: $0.07 Exit: $0.13 | Profit: 90.22% ROI | https://1ightning.com

0 · Reply

Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference

Nov 3, 2025, 6:36 PM EST - 4 weeks ago

Medifast, Inc. (MED) Q3 2025 Earnings Call Transcript

Nov 3, 2025, 4:05 PM EST - 4 weeks ago

Medifast Announces Third Quarter 2025 Financial Results

Oct 27, 2025, 8:30 AM EDT - 5 weeks ago

Medifast Announces Strategic Shift to Metabolic Health with the Introduction of Metabolic Synchronization™

Oct 21, 2025, 10:00 AM EDT - 6 weeks ago

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2025

Sep 15, 2025, 8:30 AM EDT - 2 months ago

Evidence Links 5 & 1 Plan® to Improved Metabolic Health Outcomes

Aug 4, 2025, 11:56 PM EDT - 4 months ago

Medifast, Inc. (MED) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 5:59 PM EDT - 4 months ago

Medifast (MED) Q2 Revenue Falls 37%

Aug 4, 2025, 4:05 PM EDT - 4 months ago

Medifast Announces Second Quarter 2025 Financial Results

LFMD

Jul 21, 2025, 4:05 PM EDT - 4 months ago

Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2025

Jul 3, 2025, 2:48 AM EDT - 5 months ago

Medifast: Coach Surge Fuels Growth

Apr 28, 2025, 6:03 PM EDT - 7 months ago

Medifast, Inc. (MED) Q1 2025 Earnings Call Transcript

Apr 28, 2025, 4:05 PM EDT - 7 months ago

Medifast Announces First Quarter 2025 Financial Results

LFMD

Mar 28, 2025, 9:21 AM EDT - 8 months ago

Medifast: GLP-1 Caused A Vicious MLM Flywheel Effect

Feb 18, 2025, 7:06 PM EST - 10 months ago

Medifast, Inc. (MED) Q4 2024 Earnings Call Transcript

Feb 18, 2025, 4:05 PM EST - 10 months ago

Medifast Announces Fourth Quarter and Full Year 2024 Financial Results

Feb 4, 2025, 4:05 PM EST - 10 months ago

Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024

Jan 7, 2025, 8:30 AM EST - 11 months ago

Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off

Dec 5, 2024, 8:30 AM EST - 1 year ago

Medifast Survey Finds Majority of U.S. Adults Trying to Lose Weight Agree Lifestyle Changes Are Essential – Even with Weight Loss Medications

Nov 6, 2024, 8:02 AM EST - 1 year ago

Medifast: Earnings Surprise, New AI Technologies, And Extremely Undervalued

Nov 4, 2024, 5:56 PM EST - 1 year ago

Medifast, Inc. (MED) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 4:05 PM EST - 1 year ago

Medifast Announces Third Quarter 2024 Financial Results

Oct 21, 2024, 4:05 PM EDT - 1 year ago

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024

Oct 3, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Encourages Shareholder Participation In A Securities Fraud Inquiry Into Medifast, Inc.

Oct 1, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Urges Shareholders To Join An Inquiry Into Medifast, Inc. For Possible Securities Fraud

Sep 30, 2024, 11:00 AM EDT - 1 year ago

Medifast Inc Is Being Investigated For Violating Securities Laws And Affected Investors Are Invited To Help The Schall Law Firm

Sep 28, 2024, 11:00 AM EDT - 1 year ago

Medifast Inc Is Being Investigated For Violating Securities Laws And Investors With Losses Are Urged To Contact The Schall Law Firm

Sep 27, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Invites Shareholder Participation In A Securities Fraud Inquiry Into Medifast, Inc.

Sep 26, 2024, 11:00 AM EDT - 1 year ago

Medifast Inc Is Being Investigated For Violating Securities Laws And Investors Are Urged To Contact The Schall Law Firm

Sep 25, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Invites Shareholder Participation In An Inquiry Into Medifast, Inc. For Possible Securities Fraud

Sep 24, 2024, 11:00 AM EDT - 1 year ago

Medifast Inc Is Being Investigated For Violating Securities Laws And Affected Investors Are Urged To Contact The Schall Law Firm

Sep 21, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into Medifast, Inc. For Securities Fraud

Sep 20, 2024, 11:00 AM EDT - 1 year ago

Medifast Inc May Have Violated Securities Laws And Investors Are Urged To Help The Schall Law Firm Investigate

Sep 19, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Seeks Shareholder Participation In An Inquiry Into Medifast, Inc. For Possible Securities Fraud

Sep 17, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Seeks Shareholder Contributions To A Securities Fraud Inquiry Into Medifast, Inc.

Sep 15, 2024, 11:00 AM EDT - 1 year ago

Medifast, Inc. May Have Defrauded The Public And The Schall Law Firm Invites Stockholders To Join A Securities Fraud Inquiry

$The Schall Law Firm Is Investigating Medifast Inc's Possible Securities Related Infractions And Affected Investors Can Partake$

Sep 14, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Investigating Medifast Inc's Possible Securities Related Infractions And Affected Investors Can Partake

Sep 13, 2024, 11:00 AM EDT - 1 year ago

Medifast, Inc. May Have Committed Securities Fraud And Shareholders With Losses Are Urged To Contribute To The Schall Law Firm's Inquiry

$The Schall Law Firm Is Looking Into Medifast Inc's Possible Securities Law Infractions And Investors Are Invited To Reach Out$

Sep 12, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Looking Into Medifast Inc's Possible Securities Law Infractions And Investors Are Invited To Reach Out

Sep 11, 2024, 11:00 AM EDT - 1 year ago

Medifast, Inc. May Have Committed Securities Fraud And Shareholders Can Join The Schall Law Firm's Inquiry

Sep 9, 2024, 11:00 AM EDT - 1 year ago

Medifast, Inc. Might Have Committed Securities Fraud And Impacted Shareholders Can Join The Schall Law Firm's Inquiry

Sep 7, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Looking Into Whether Medifast Inc Violated Securities Laws And Investors Can Partake In The Investigation

Sep 5, 2024, 11:00 AM EDT - 1 year ago

Medifast Inc Might Have Committed Securities Fraud And Investors Should Join The Schall Law Firm's Investigation

Sep 4, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Looking Into Whether Medifast Inc. Violated Securities Laws And Impacted Shareholders Can Reach Out

Sep 3, 2024, 11:00 AM EDT - 1 year ago

Investors With Losses In Medifast Inc Are Encouraged To Help The Schall Law Firm In A Securities Fraud Investigation

bginvest Dec. 4 at 8:40 PM

1 · Reply

Iightning Dec. 4 at 8:11 AM

1ightning® Premium Options Alert (Actionable) Ticker: $MED Contract: Dec 19 $10C Entry: 1.07 Exit: 2.13 Return: +98.37% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

Investor6 Dec. 3 at 5:33 PM

0 · Reply

Iightning Dec. 2 at 2:46 AM

0 · Reply

Estimize Nov. 26 at 9:00 PM

Wall St is expecting -0.82 EPS for $MED Q4 [Reporting 02/24 AMC] http://www.estimize.com/intro/med?chart=historical&metric_name=eps&utm_con

0 · Reply

Iightning Nov. 26 at 5:46 AM

1ightning® Options Trade Alert (Actionable) | Buy $MED Dec 19 $12 Call | Enter: $0.07 Exit: $0.13 | Profit: 90.22% ROI | https://1ightning.com

0 · Reply

FRAGMENTS Nov. 26 at 3:08 AM

$CNC $CNC $UNH $MED $MPW

1 · Reply

Iightning Nov. 25 at 3:55 PM

1ightning® Options Trade Alert (Actionable) | Buy $MED Dec 19 $12 Call | Enter: $0.07 Exit: $0.13 | Profit: 90.22% ROI | https://1ightning.com

0 · Reply

FRAGMENTS Nov. 25 at 1:15 PM

0 · Reply

Iightning Nov. 25 at 4:49 AM

1ightning® Options Trade Alert (Actionable) | Buy $MED Dec 19 $12 Call | Enter: $0.07 Exit: $0.13 | Profit: 90.22% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 22 at 2:00 AM

1ightning® Options Trade Alert (Actionable) | Buy $MED Dec 19 $12 Call | Enter: $0.18 Exit: $0.27 | Profit: 53.56% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 21 at 5:22 AM

1ightning® Options Trade Alert (Actionable) | Buy $MED Dec 19 $12 Call | Enter: $0.18 Exit: $0.27 | Profit: 53.56% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 20 at 3:11 AM

1ightning® Options Trade Alert (Actionable) | Buy $MED Dec 19 $12 Call | Enter: $0.18 Exit: $0.27 | Profit: 53.56% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 19 at 10:56 AM

1ightning® Options Trade Alert (Actionable) | Buy $MED Dec 19 $12 Call | Enter: $0.18 Exit: $0.27 | Profit: 53.56% ROI | https://1ightning.com

0 · Reply

NVDAMillionaire Nov. 18 at 9:27 AM

$MED Brilliant piece that captures MED's situation perfectly. So if you want to update your understanding of MED or get to know MED better, this is essential reading. https://beyondspx.com/quote/MED/analysis/medifast-s-metabolic-health-revolution-fueling-future-growth-through-coach-led-transformation-nyse-med

0 · Reply

SuperGreenToday Nov. 11 at 1:39 PM

$MED Share Price: $11.80 Contract Selected: Jun 18, 2026 $10 Calls Buy Zone: $2.03 – $2.50 Target Zone: $3.75 – $4.59 Potential Upside: 75% ROI Time to Expiration: 218 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

justcomments Nov. 5 at 7:08 PM

$MED I noticed a pattern in MED. They say they lost money. Then the cash in bank increases. This quarter they made 10.8M dollars. That's 98 cents per share. That's a lot of money for a small cap like this. They say they had a really bad quarter. The profit margin fell from 70% to 69.5%. Is that right? Did I hear it correctly? That's a disaster, no? What's the next quarter profit margin? 69.3%? Keep shorting.

0 · Reply

justcomments Nov. 5 at 6:43 PM

$MED OZEMPIC awareness is slowly spreading. Very slowly. Pancreatitis cancer. Thyroid cancer. Kidney damage. Heart failure. Gastrointestinal paralysis. Eye problems. This is serious. When these people decide to go back to food - it will be interesting for MED.

0 · Reply

_StockFox_ Nov. 5 at 12:48 AM

$MED added a few shares today $SPY $QQQ

0 · Reply

ZacksResearch Nov. 4 at 5:09 PM

$MED feels the pinch from fewer OPTAVIA Coaches, but shifting focus could spark a new phase 🔄💪 Q3 results showed coach declines weighing on performance, yet the company’s pivot toward metabolic health signals a strategic growth move. Full story on the transition here 👉 https://www.zacks.com/stock/news/2784765/medifasts-q3-loss-wider-than-expected-sales-decline-36-yy?cid=sm-stocktwits-2-2784765-teaser-19330&ADID=SYND_STOCKTWITS_TWEET_2_2784765_TEASER_19330

0 · Reply

ZacksResearch Nov. 4 at 4:09 PM

$MED misses on EPS — is the shift to metabolic health the right move? 🤔 📉 EPS loss of 21 cents vs. expected 1 cent loss 📊 Revenue of $89.4M beats estimate but drops 36.2% YoY 🚪 Active earning OPTAVIA coaches down 35% amid GLP-1 adoption Full breakdown here 👉 https://www.zacks.com/stock/news/2784765/medifasts-q3-loss-wider-than-expected-sales-decline-36-yy?cid=sm-stocktwits-2-2784765-body-19331&ADID=SYND_STOCKTWITS_TWEET_2_2784765_BODY_19331

0 · Reply

DataJim Nov. 4 at 3:48 PM

$MED Have they given any insight into when they will return to profitability? the Q4 projected loss is the biggest one yet.

1 · Reply

Market Cap	120.79M
Revenue (ttm)	602.46M
Net Income (ttm)	2.09M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.35%
Debt to Equity Ratio	0.00

Volume	305,423
Avg Vol	168,868
Day's Range	N/A - N/A
Shares Out	10.99M
Stochastic %K	86%
Beta	0.48
Analysts	Hold
Price Target	$15.00